Vizilite Plus
We are Serious about early detection of Oral Cancer
In our continuing efforts to provide the most advanced technology and highest quality care available to our patients, we are proud to announce the inclusion of the Vizilite Plus exam as an integral part of our annual comprehensive oral cancer screening program.
About Oral Cancer
Most people are surprised to learn that one American dies every hour from oral cancer; a death rate that has remained virtually unchanged for more than 40 years. In fact, recent statistics published by the American Cancer Society indicate that while the incidence and death rates for cancers overall has decreased, the incidence of oral cancer has increased by 5.5% and the death rate has increased by 1.5%.
Oral cancer is far too often discovered in late stage development, the primary reason for the consistently high death rate. Oral cancer treatment often results in disfiguring effects on patients, and can seriously compromise their quality of life. Early detection and diagnosis can make a tremendous difference in life expectancy; oral cancer is 90% curable when found in its early stages. Unfortunately, 70% of oral cancers are diagnosed in the late stages, III and IV, leading to a five-year survival rate of 57%.
The Deadly Statistics
- Every hour of every day, one American dies of oral cancer.
- The mortality rate associated with oral cancer has not improved significantly in the last 40 years.
- The death rate in the United States for oral cancer is higher than that of cervical cancer, Hodgkin's disease, cancer of the brain, liver, testes, kidney, or ovary.
- More than 30,000 Americans will receive an oral cancer diagnosis this year. In five years, only 57% will still be alive.
- 27% of oral cancer victims do not use tobacco or alcohol, are under the age of 40, and have no other lifestyle risk factors.
The ViziLite Plus exam can help your dentist identify abnormal tissue, that might develop into oral cancer.
An annual ViziLite Plus exam, in combination with a regular visual examination, provides a comprehensive oral screening procedure for patients at increased risk for oral cancer. The ViziLite Plus exam is painless and fast, and could help save your life.
ViziLite Plus is performed immediately following a regular visual examination
- First, you will be instructed to rinse with a cleansing solution
- Next, the overhead lighting will be dimmed.
- Then, your dentist will examine your mouth using ViziLite Plus, a specially designed light technology.
How ViziLite® Plus Works
ViziLite Plus with TBlue™ is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. It is comprised of a chemiluminescent light source (ViziLite) to improve the identification of lesions and a blue phenothiazine dye to mark those lesions identified by ViziLite. ViziLitePlus with TBlue™ is designed to be used in a patient population at increased risk for oral cancer.
ViziLite Lumenoscopy™
Who's at Risk?
- Fact: 27% of oral cancers occur in people who don’t smoke and have no other risk factors.
Increased risk
- Patients age 18-39
High risk
- Patients age 40 and older
- Tobacco users (any type, any age, within 10 years)
Highest risk
- Patients age 40 and older with lifestyle risk factors
(Tobacco, alcohol, HPV) - Patients with history of oral cancer
source: www.Vizilite.com